Kirk Ways

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Samir Gharib, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kirk Ways:

Company Role Class Num Shares Value Price $ Report Date Ownership
SPRUCE BIOSCIENCES, INC. Interim Chief Medical Officer, Director Common Stock 1,250 $91,912 $73.53 11 Dec 2025 Direct
SPRUCE BIOSCIENCES, INC. Interim Chief Medical Officer, Director Restricted Stock Units 3,750 11 Dec 2025 Direct
SPRUCE BIOSCIENCES, INC. Interim Chief Medical Officer, Director Stock Option (Right to Buy) 0 11 Dec 2025 Direct

Insider Reports Filed by Kirk Ways

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRB SPRUCE BIOSCIENCES, INC. 11 Dec 2025 7 $0 4 Interim Chief Medical Officer, Director 21 Jan 2026, 16:04
SPRB SPRUCE BIOSCIENCES, INC. 23 Jul 2025 1 $0 4 Interim Chief Medical Officer, Director 24 Jul 2025, 19:34
SPRB SPRUCE BIOSCIENCES, INC. 22 May 2024 1 $0 4 Director 24 May 2024, 16:29
SPRB SPRUCE BIOSCIENCES, INC. 25 May 2023 1 $0 4 Director 26 May 2023, 17:41
SPRB SPRUCE BIOSCIENCES, INC. 25 May 2022 1 $0 4 Director 27 May 2022, 16:13
SPRB SPRUCE BIOSCIENCES, INC. 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:21
SPRB SPRUCE BIOSCIENCES, INC. 23 Jun 2021 0 $0 3 Director 25 Jun 2021, 16:20